Provision of Virology/Bacterial Testing Services by Micropathology Ltd

Location

Gloucester

Description

Micropathology Ltd provide GHFT a testing service for virology/bacterial request by PCR/serology/sequencing and the reporting of these results.

Total Quantity or Scope

Micropathology Ltd provide GHFT a testing service for virology/bacterial request by PCR/serology/sequencing and the reporting of these results.GHFT are intending to award a contract to Mircropathology Ltd who is the existing provider, by following Direct Award C of the PSRThe approximate lifetime value of the contract is £123,000The contract covers 08.09.2025 until 07.09.2028

Award Detail

Award Criteria

CPV Codes

• 85111800 - Pathology services

Indicators

• Award on basis of price.

Legal Justification

This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. The standstill period begins on the day after the publication of this notice. Representations by providers must be made to the relevant authority by Friday 6th March 2026. This contract has not yet formally been awarded; this notice serves as an intention to award under PSR.

Other Information

This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. The standstill period begins on the day after the publication of this notice. Representations by providers must be made to decision makers by Friday 6th March 2026.Decision Makers include:Sarah BrownJonathan LewisWhen applying the 5 key criteria to this provision, GHFT applied the following:• Quality and Innovation (30%)Due to working with this provider for several years, they have proven to provide quality testing and reporting for GHFT patients and have been able to ensure future care planning can be implemented. • Value (25%)Due to the capacity demands, GHFT are unable to meet all pathology needs and therefore outsourcing activity is a must to be able to keep up with demand. This is a cost and volume contract so GHFT only pay for the tests that are requested and as the contract is for send away testing, it also ensures that testing is easily accessible for patients and reporting has a quick turnaround to ensure patient care can be appropriately planned. • Integration, Collaboration and Service Sustainability (15%)Micropathology Ltd are a well-established provider of virology/bacterial requests by PCR/serology/sequencing reporting. GHFT has a positive working relationship and work collaboratively to provide testing/reporting needs for patients. • Improving Access (20%)Due to being send away tests, GHFT can access the required testing/reporting needs quickly and will therefore allow testing to be accessible for all and improves health inequalities. • Social Value (15%)Being able to contract for this support allows patients to access services quickly. Due to being send away tests, patients are not required to attend any further clinics and as well as not having to attend additional appointments to access services. There were no conflicts of interests declared.